Roxadustat – a representative of hypoxia-inducible factor prolyl hydroxylase inhibitors: mechanism of action, safety, and efficacy
Medical Science · 27.02.2026 · 30 (168) · 1-10
DOI: 10.54905/disssi.v30i168.e39ms3797 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science, online erschienen am 27.02.2026. Verfasst von Michał Borowski und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Borowski, M., Leśniak, J. A., Leśniak, N. M., Patrzykąt, K. M., Zakrzewska, A. M., Popielarska, K., Niwińska, K. E., Michalak, J. A., Midera, A., & Augustyn, M. (2026). Roxadustat – a representative of hypoxia-inducible factor prolyl hydroxylase inhibitors: mechanism of action, safety, and efficacy. Medical Science, 30(168), 1-10. https://doi.org/10.54905/disssi.v30i168.e39ms3797
Vancouver
Borowski M, Leśniak JA, Leśniak NM, Patrzykąt KM, Zakrzewska AM, Popielarska K, et al. Roxadustat – a representative of hypoxia-inducible factor prolyl hydroxylase inhibitors: mechanism of action, safety, and efficacy. Medical Science. 2026;30(168):1-10. doi:10.54905/disssi.v30i168.e39ms3797
BibTeX
@article{Borowski2026,
author = {Borowski, Michał and Leśniak, Julia Aleksandra and Leśniak, Natalia Maria and Patrzykąt, Klaudia Martyna and Zakrzewska, Anna Maria and Popielarska, Kinga and Niwińska, Klaudia Elżbieta and Michalak, Julia Agnieszka and Midera, Aleksander and Augustyn, Monika},
title = {Roxadustat – a representative of hypoxia-inducible factor prolyl hydroxylase inhibitors: mechanism of action, safety, and efficacy},
journal = {Medical Science},
year = {2026},
volume = {30},
number = {168},
pages = {1--10},
doi = {10.54905/disssi.v30i168.e39ms3797}
}
EUVIMED